Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SIGMAPHARM LABS LLC

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 30
  • 0 comments

FDA approve FLUCYTOSINE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 28
  • 0 comments

FDA approve MELOXICAM

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 25
  • 0 comments

FDA approve FLUDROCORTISONE ACETATE

Comment Full text

PROPEL PHARMA

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 25
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 26
  • 0 comments

FDA approve ZOLPIDEM TARTRATE

Comment Full text

SENTYNL THERAPS INC

  • FDA Approval
  • Oct. 28, 2022, 09:22 UTC
  • 38
  • 0 comments

FDA approve FOSDENOPTERIN HYDROBROMIDE

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Oct. 28, 2022, 09:22 UTC
  • 37
  • 0 comments

FDA approve OLAPARIB

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 34
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

GRANULES

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 36
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

STEMLINE THERAPEUTICS INC

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 35
  • 0 comments

FDA approve TAGRAXOFUSP-ERZS

Comment Full text
  • Previous
  • 950
  • 951
  • 952
  • 953
  • 954
  • Next

Search

News categories

  • Technical Exchange News(14802)
  • Event(6229)
  • SEC News(399493)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243696)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin